Edegem

• Drug-Drug Interaction Study With BIA 28-6156 and Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy Participants Ended
  2025-520840-14-00 3 2025-04-29 Healthy volunteers
• A clinical study of MK-1403 in healthy people (MK-1403-002) Ended
  2023-507239-39-00 3 2025-04-25 Atherosclerosis
• A trial to learn how safe AZD0022 is, how well it works, and how it moves throughout the body over time in adults with tumors that have a KR … Ended
  2024-516699-14-00 7 2025-04-23 Non Small Cell Lung Cancer Colorectal Cancer Pancreatic Ductal Adenoca
• A study to investigate the bioavailability of the SAR444656 test formulation and the food effect on the SAR444656 test formulation in health … Ended
  2024-515621-28-00 3 2025-04-17 Healthy Volunteer
• A study to investigate safety, tolerability, pharmacokinetics and efficacy of REM0045392 compared with placebo in healthy participants Ended
  2025-520454-11-00 1 2025-03-20 Alzheimer
• A clinical study of MK-2420 in healthy people (MK-2420-002) Ended
  2024-516548-25-00 3 2025-03-12 Rheumatoid arthritis
• Not applicable Ended
  2024-518150-17-00 3 2025-03-10 Non-cystic fibrosis bronchiectasis
• Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults. Ended
  2024-515285-14-00 1 2025-03-04 Healthy Volunteers
• A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes me … Ended
  2023-506545-27-01 4 2025-01-28 Diabetes mellitus, Type 1
• A clinical study of MK-2828 in healthy people (MK-2828-002) Ended
  2024-518229-13-00 3 2025-01-21 Atherosclerosis
• A study to test how different doses of BI 3731579 are tolerated by healthy people Ended
  2024-517209-95-00 3 2024-12-11 Healthy volunteer trial
• A study to assess the effects of efgartigimod on emasiprubart in healthy adult participants Ended
  2024-517511-70-00 3 2024-12-04 not applicable
• Evaluation of safety, side effects and how the inhaled drug CHF10073 is absorbed, modified and removed from the body when administered alone … Ended
  2024-515442-17-00 1 2024-12-03 Pulmonary fibrosis
• Evaluation of the CHF 5993 concentration in blood, after inhalation with two different devices, (NEXThaler® versus pMDI), with and without A … Ended
  2024-512792-13-00 3 2024-11-13 Asthma
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom … Ended
  2024-512848-30-00 4 2024-11-12 HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER
• A Study to Learn How Safe EV25 is, the Amount of EV25 in the Body Over a Period of Time, and the Effects of EV25 on the Body in Adult Health … Ended
  2024-514832-26-00 7 2024-11-12 Virus Influenza
• Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures – SHIN … Ended
  2023-508812-45-00 10 2024-11-11 Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures
• A clinical study of MK-3508 in healthy people (MK-3508-006) Ended
  2024-516619-26-00 3 2024-11-04 Respiratory syncytial virus infection
• A clinical study of MK-1403 in healthy men (MK-1403-004) Ended
  2024-514629-52-00 3 2024-10-28 Atherosclerosis
• A study to test how well different doses of BI 3810477 are tolerated by healthy men Ended
  2024-513419-28-00 1 2024-10-22 Healthy volunteer trial
• A clinical study of the V540A vaccine in healthy adults (V540A-001) Ended
  2024-515785-14-00 1 2024-10-22 Human Papilloma virus
• A clinical study of MK-3214 in healthy people (MK-3214-001) Ended
  2024-516016-17-00 1 2024-10-22 Hypercholesterolaemia
• A Study to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Influenza Vaccine Compared with a Licensed Influenza … Ended
  2024-516240-26-00 5 2024-10-11 Influenza
• A study to evaluate the safety and tolerability of JNJ-70035108 and to evaluate how long JNJ-70035108 stays in and acts on the body (pharmac … Ended
  2024-514067-25-00 1 2024-09-23 Inflammatory Conditions

Showing 433–456 of 583 trials